PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Institut Pasteur Cote d'Ivoire (IPCI) was created in 1972 and is part of the Ministry of Research and
Education. The institution includes six scientific departments and employs 120 highly qualified staff,
including biologists, biotechnologists and research scientists. The IPCI has five primary missions: (1)
research in biomedical and environmental science; (2) training in laboratory practices; (3) provision of
laboratory services (diagnosis and quality control); (4) routine microbiology surveillance and laboratory
support for outbreak investigations; and (5) technical support to public health programs. Despite the
availability of highly qualified human resources, its infrastructure and equipment are badly in need of being
updated and adapted to the current needs of the country associated with fulfilling its national mandate. In
2007, IPCI was designated by inter-ministerial (Ministry of Research and Ministry of Health) decree as the
national reference laboratory for TB diagnosis and surveillance of infectious diseases. In FY08, IPCI
became a subpartner of the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), a PEPFAR prime
partner.
In FY09, the USG team will seek to continue and expand its support to IPCI by developing a sole-source
award for the implementation of TB, OIs, and STI diagnosis and a national EQA program at six STI clinic
laboratories and six regional laboratories. With the technical assistance of ASM, PEPFAR will assist IPCI to
strengthen diagnostics of TB, OIs, and STIs. Specific activities with respect to assistance for OIs and STIs
will include: (1) evaluation of OI (other than TB) and STI diagnostic capacity in-country; (2) strengthening
and expansion of core functions of the National Microbiology Reference Laboratory (IPCI); (3) collaboration
with other key national labs to develop and facilitate basic microbiology workshops to be presented at six
regional laboratories; (4) follow-up mentoring in the six labs where microbiology workshops have been
presented to ensure proper retention and implementation of learned procedures; (5) provision of onsite
training of IPCI staff in the monitoring and evaluation of TB, OI, and STI training activities; (6) assistance
with development of the laboratory quality assurance program for microbiology to include a training plan for
laboratory personnel and guidelines for supervision and oversight of quality standards; (7) strengthen pre-
service, in-service, and continuing education for medical microbiologists; (8) development and
implementation of quality management systems at all 12 sites. Support logistics of quality-assurance
systems for TB/OI-related laboratory techniques, including training, procurement, infrastructure
improvement, and specimen transport, supervision, and regular feedback reports to network laboratories.
IPCI will provide at least two QA/QC site visits to each of the 12 laboratories this year; (9) surveillance of TB
and OIs (S. pneumoniae), STI (N. gonorrhoeae) resistant strains; and (10) develop a monitoring and
evaluation program.
New/Continuing Activity: New Activity
Continuing Activity:
Table 3.3.16:
